Literature DB >> 31186877

Secondary prophylaxis in patients who have experienced portal hypertensive bleeding.

Carlo Merkel1, Sara Montagnese1.   

Abstract

Entities:  

Year:  2012        PMID： 31186877      PMCID： PMC6499288          DOI： 10.1002/cld.86

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  15 in total

1.  Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.

Authors:  G V Papatheodoridis; J Goulis; G Leandro; D Patch; A K Burroughs
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

Review 2.  Pharmacological treatment of portal hypertension: an evidence-based approach.

Authors:  G D'Amico; L Pagliaro; J Bosch
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

3.  Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.

Authors:  C Villanueva; J Miñana; J Ortiz; A Gallego; G Soriano; X Torras; S Sáinz; J Boadas; X Cussó; C Guarner; J Balanzó
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

4.  American Association for the Study of Liver Diseases Practice Guidelines: the role of transjugular intrahepatic portosystemic shunt creation in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  J Vasc Interv Radiol       Date:  2005-05       Impact factor: 3.464

5.  Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial.

Authors:  Joaquin de la Peña; Enric Brullet; Eloy Sanchez-Hernández; Monserrat Rivero; Mercedes Vergara; Jose Luis Martin-Lorente; Covadonga Garcia Suárez
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

6.  TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.

Authors:  Angels Escorsell; Rafael Bañares; Juan Carlos García-Pagán; Rosa Gilabert; Eduardo Moitinho; Belén Piqueras; Concepció Bru; Antonio Echenagusia; Alicia Granados; Jaume Bosch
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

7.  Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial.

Authors:  G H Lo; K H Lai; J S Cheng; M H Chen; H C Huang; P I Hsu; C K Lin
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

8.  Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.

Authors:  Nicolas Carbonell; Arnaud Pauwels; Lawrence Serfaty; Olivier Fourdan; Victor George Lévy; Raoul Poupon
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

9.  A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.

Authors:  D Patch; C A Sabin; J Goulis; G Gerunda; L Greenslade; C Merkel; A K Burroughs
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

10.  Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.

Authors:  Gin-Ho Lo; Wen-Chi Chen; Mei-Hsiu Chen; Ping-I Hsu; Chiun-Ku Lin; Wei-Lun Tsai; Kwok-Hung Lai
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.